Brian J Coffey, MD
Assistant Professor, Neurology
Biography
Dr. Brian J. Coffey is a neurointensivist at Boston Medical Center and assistant professor of Neurology at Boston University Chobanian & Avedisian School of Medicine. Dr. Coffey treats patients admitted to the Neurosciences Intensive Care Unit (NSICU), specializing in the treatment of severe brain injury, as well as other neurological conditions that require ICU care. He is passionate about providing exceptional care to patients and supporting their families. Dr. Coffey’s past research examined how the brain recovers language function after severe traumatic brain injury. His current research focuses on non-invasive monitoring of cerebral blood flow in the ICU after acute brain injury, such as after cardiac arrest, stroke, and traumatic brain injury. He aims to learn more about microcirculatory blood flow in the human brain post-injury, with the goal of determining if continuous cerebral blood flow monitoring could have clinical utility, possibly optimizing management approaches in the neuro ICU, improving patient outcomes, and aiding neuroprognostication. Dr. Coffey received his medical degree from Tufts University School of Medicine and his bachelor’s degree from Northeastern University. He completed his residency in neurology at UF Health Shands Hospital at the University of Florida, followed by his fellowship in neurocritical care at Boston Medical Center. Dr. Coffey is a member of the American Academy of Neurology, Neurocritical Care Society, American Medical Association, and the Massachusetts Medical Society.
Education
- Tufts University School of Medicine, MD
- Northeastern University, BS
Publications
- Published on 5/1/2023
Oldak SE, Bernal JA, Bez Y, Coffey BJ. Rational Psychopharmacological and Psychotherapeutic Treatment of a 14-Year-Old Female with Functional Neurological Symptoms Disorder and Depression. J Child Adolesc Psychopharmacol. 2023 May; 33(4):158-161. PMID: 37204276.
Read at: PubMed - Published on 8/1/2022
Bez Y, Kompella S, Summerson A, Coffey BJ. Management of COVID-19 Infection-Associated Flare in an Adolescent with Pediatric Acute Neuropsychiatric Syndrome and Obsessive-Compulsive Disorder. J Child Adolesc Psychopharmacol. 2022 Aug; 32(6):368-371. PMID: 35960228.
Read at: PubMed - Published on 9/21/2021
Coffey BJ, Threlkeld ZD, Foulkes AS, Bodien YG, Edlow BL. Reemergence of the language network during recovery from severe traumatic brain injury: A pilot functional MRI study. Brain Inj. 2021 Nov 10; 35(12-13):1552-1562. PMID: 34546806.
Read at: PubMed - Published on 6/15/2020
Coffey BJ. Potential New Tourette Syndrome Treatments: Will Real-Time Neurofeedback Have a Role? Biol Psychiatry. 2020 Jun 15; 87(12):1019-1021. PMID: 32498788.
Read at: PubMed - Published on 5/1/2015
Berg A, Byrne R, Coffey BJ. Neuroleptic Malignant Syndrome in a Boy with NMDA Receptor Encephalitis. J Child Adolesc Psychopharmacol. 2015 May; 25(4):368-71. PMID: 25978744.
Read at: PubMed - Published on 3/13/2013
Andriani G, Amata E, Beatty J, Clements Z, Coffey BJ, Courtemanche G, Devine W, Erath J, Juda CE, Wawrzak Z, Wood JT, Lepesheva GI, Rodriguez A, Pollastri MP. Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth. J Med Chem. 2013 Mar 28; 56(6):2556-67. PMID: 23448316.
Read at: PubMed